Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Grants Golden Helix Sweeping Rights to PBAT Software

NEW YORK (GenomeWeb News) – Harvard University has granted Golden Helix exclusive rights to its statistical software that analyzes family-based association studies, Golden Helix said today.
 
The worldwide, royalty-bearing license gives Golden Helix the right to use, copy, and make improvements to the PBAT program. The company can also sell licenses for commercial and non-profit research.
 
PBAT implements a two-step method of identifying and testing genes that may contribute to disease. Christoph Lange and Nan Laird of the Harvard School of Public Health developed the method for the program.
 
The software was available from Lange’s web site as a command-line interface. Golden Helix has developed a version with a graphical interface that can be used as a stand-along application or with its HelixTree Genetic Analysis Software.
 
Financial details were not disclosed.

Filed under

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.